Financhill
Back

Monopar Therapeutics Quote, Financials, Valuation and Earnings

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!
Buy
63

MNPR
Monopar Therapeutics

Last Price:
0.77
Seasonality Move:
-14.68%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Monopar Therapeutics Price Quote

$0.77
+0.01 (+1.65%)
(Updated: May 7, 2024 at 4:25 PM ET)

Monopar Therapeutics Key Stats

Buy
63
Monopar Therapeutics (MNPR) is a Buy

Day range:
$0.70 - $0.80
52-week range:
$0.27 - $1.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.37%

Volume:
81K
Avg. volume:
140.4K
1-year change:
-23.59%
Market cap:
$13.2M
Revenue:
$0
EPS:
$-0.61

How Much Does Monopar Therapeutics Make?

Data Unavailable

Is Monopar Therapeutics Growing As A Company?

Data Unavailable

Monopar Therapeutics Stock Price Performance

What Is Monopar Therapeutics 52-Week High & Low?

Monopar Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Monopar Therapeutics?

Is Monopar Therapeutics Cash Flow Positive?

  • What Is MNPR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.9M
  • What Is Monopar Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2M
  • What Is Monopar Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $4.9M

Monopar Therapeutics Return On Invested Capital

Data Unavailable

Monopar Therapeutics Earnings Date & Stock Price

Monopar Therapeutics Competitors

  • Who Are Monopar Therapeutics's Competitors?
    Below is a list of companies who compete with Monopar Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • SeaStar Medical Holding Corp (ICU)
    • Motus GI Holdings Inc (MOTS)
    • Xtant Medical Holdings Inc (XTNT)

Monopar Therapeutics Dividend Yield

Data Unavailable

Monopar Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 29.41%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.36
Upside from Last Price: 344%

Major Shareholders

  • How many MNPR shares are owned by institutional investors?
    311.7K MNPR shares are owned by institutional investors
  • How many MNPR shares are owned by insiders?
    634.2K MNPR shares are owned by insiders